Speaker Profile
FSA, FCA, MAAA, Partner and Consulting Actuary, Axene Health Partners
Biography
Gregory Warren serves as Partner and Consulting Actuary at Axene Health Partners. He previously served as SVP and Chief Actuary for Optum Advisory Services, leading over 270 associates in the global provision of actuarial, underwriting and pharmacy advisory services and StepWise underwriting software. He also founded and led the Pharmacy Advisory Services group at Optum. Before Optum, Greg spent over 8 years at Walgreens including responsibility for all of Walgreens Health Initiatives PBM finance, pricing and underwriting, reporting and analytics and pharmacy network functions. He also previously served as a Senior Health Actuary and pharmacy benefits consultant at The Segal Company where he coordinated Segals Midwest region pharmacy benefits consulting services. Greg started his career as an actuarial analyst at Trustmark Insurance Company and then Celtic Insurance Company. Greg founded and leads the Pharmacy Subgroup for the Society of Actuaries leading most of the SOAs pharmacy related research and educational efforts.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
Kelly E. Caudle, St. Jude
The PMWC 2024 Pharmacogenomics (PGx) Track focuses on advancing standardization in pharmacogenomics to achieve better clinical outcomes. The importance of standardization in PGx cannot be overstated as it can help to improve patient care in several ways. Standardization of clinical laboratory processes can help ensure consistent and accurate test results, which is crucial for making informed clinical decisions. Standardization of reporting can help to ensure that test results are communicated in a clear and understandable manner to clinicians and patients. Standardization of pharmacogenomic test ordering and reimbursement can help to ensure that patients have access to the tests they need, regardless of their location or financial situation. Standardization of PGx education can help to ensure that healthcare professionals have the knowledge and skills they need to use PGx in clinical practice effectively. Finally, clinical pearls and outcome data can help to demonstrate the value of PGx in improving patient outcomes and informing clinical decision-making.
- PMWC 2024 PGx Award Ceremony:
Pioneer Honoree: Andrea Gaedigk, Children’s Mercy Research Institute (CMRI)
Luminary Honoree: Teri E. Klein, Stanford - Standardization: Key to Advancing Precision Medicine
Opening Talk: Kelly E. Caudle, St. Jude
- Current and Desired States of Standardization of Clinical Laboratory Processes
Chair: Andrea Gaedigk, Children’s Mercy Research Institute (CMRI)
- Vicky Pratt, Agena Bioscience
- FIRESIDE CHAT
Chair: Damon Hostin, Illumina
- Howard McLeod, Utah Tech University
- Current and Desired States of Standardization of Reporting (PANEL)
Chair: Chad Bousman, University of Calgary
- Lisa Brown, Great Scott!
- Vicky Pratt, Agena Bioscience
- Current and Desired States of Standardization of Pharmacogenomic Test Ordering and Reimbursement (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Jai Patel, Atrium Health
- Greg Warren, Axene Health Partners - Current and Desired State of PGx Education
Chair: Phil Empey, University of Pittsburgh
- Michelle Whirl Carrillo, Stanford
- Current and Desired State of the Patient Experience in Precision Medicine (PANEL)
Chair: Avni Santani, LetsGetChecked
- Kristy Crooks, University of Colorado - Stuart Scott, Stanford - Clinical Pearls and Outcome Data: Advancing the Adoption of Pharmacogenomics in Clinical Practice
Chair: Kelly E. Caudle, St. Jude
- Larisa H Cavallari, University of Florida
- Jeff Bishop, University of Minnesota - PMWC Showcase
- Bani Tamraz, UCSF
